CrushSCI.com
116.2平均天数
99中位天数
53最短天数
272最长天数
882025发文量

Paper Review Records

全部论文审稿周期

11 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

155 天

A novel DMTN :: HMGA2 rearrangement drives aberrant reactivation of HMGA2 with profibrotic and type I interferon–suppressive signaling

作者
Yan Lin; Sujuan Zhou; Mei Yang; Nan Chen; Jintao Xu; Xingping Lang; Fan Yang; Sheng Xiao; Lijun Meng; Shouli Wang; Liying Zhang展开收起
作者单位
1. Department of Hematology, The First People's Hospital of Changzhou; 2. Third Affiliated Hospital of Soochow University; 3. Advanced Molecular Pathology Institute of Soochow University and SANO; 4. Suzhou Sano Precision Medicine Ltd, SANO Medical Laboratories; 5. Department of Pathology; 6. School of Basic Medical Sciences of Soochow University; 7. Department of Hematology; 8. Affiliated Hospital of Nantong University; 9. The Second Affiliated Hospital of Soochow University展开收起
PDF源文件 DOI 网页
99 天

RecurIndex-derived molecular features associated with total pathological complete response in triple-negative breast cancer: An exploratory prospective cohort study with single-cell transcriptomic contextualization

作者
Meilin Chen; Xiwen Yan; Qifan Chen; Jiayi Bei; Zheng Pan; Tian Zhang; Weihao Cheng; Lu Xu; Feng Jin; Yan Gao; Zining Jin; Ang Zheng展开收起
作者单位
1. Beijing Chaoyang Hospital, Capital Medical University, Beijing Chaoyang Hospital; 2. Department of Breast Surgery, The First Hospital of China Medical University; 3. Department of Medical Oncology, The First Hospital of China Medical University; 4. Department of Human Anatomy, School of Basic Medical Sciences, Capital Medical University展开收起
PDF源文件 DOI 网页
92 天

UBE2S promotes gastric cancer progression through RACGAP1 stabilization associated with K292-dependent K63-linked ubiquitination

作者
HeFei Cheng; Ziqing Zhou; Qirun Cheng; Ziqi Sui展开收起
作者单位
1. Department of Gastroenterology, The First People’s Hospital of Linping District; 2. Department of Gastroenterology, The Second Affiliated Hospital of Zhejiang Chinese Medical University; 3. Department of Gastroenterology, Zhejiang Hospital展开收起
PDF源文件 DOI 网页
111 天

ARHGAP40 suppresses clear cell renal cell carcinoma progression and is associated with altered glutamine-related metabolism and redox balance

作者
Na You; Xiaoxia Wang; Caizhu Wang; Long Ma; Yanli Lyu; Han Liu; Fan Yang; Jiandong Wang; Longjiang Zhang; Jufang Wang展开收起
作者单位
1. School of Biology and Biological Engineering, South China University of Technology; 2. Guangzhou Huayin Medical Laboratory Center Co, Ltd; 3. Guangzhou Huayin Health Group Co., Ltd; 4. Department of Pathology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University; 5. Department of Radiology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University; 6. School of Life Sciences, Jiangsu Key Laboratory for Molecular and Medical Biotechnology, Nanjing Normal University展开收起
PDF源文件 DOI 网页
178 天

Inhibition of WNT signaling sensitizes CRC cells to anti-tumor effects of retinoids: basis for new drug combinations in oncology

作者
Victoria O. Hunsu; Caroline O. B. Facey; Lynn M. Opdenaker; Bruce M. Boman展开收起
作者单位
1. Cawley Center for Translational Cancer Research, Helen F. Graham Cancer Center & Research Institute; 2. Department of Biological Sciences, University of Delaware; 3. Department of Pharmacology & Experimental Therapeutics, Thomas Jefferson University展开收起
PDF源文件 DOI 网页
108 天

Elevated miR-103b in exosomes derived from brain-metastatic triple-negative breast cancer cells remodels the brain pre-metastatic niche (PMN)

作者
Li Zhou; Jin Ke; Shanlan Zhang; Sufang Xiao; Hui Zhang; Shan Liu; Li Liu; Mingan Liu; Zuohua Lu; Songguo Zheng展开收起
作者单位
1. Department of Oncology, Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine; 2. Department of Clinical Laboratory, Pudong Gongli Hospital, Shanghai University of Medicine & Health Sciences; 3. Department of Immunology, The School of Cell & Gene Therapy, Songjiang Research Institute and Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine; 4. State Key Lab of Innovative Immune Therapy, Shanghai Jiao Tong University展开收起
PDF源文件 DOI 网页

FAQ

CANCER BIOLOGY & THERAPY审稿要多久?

截至2026-11-19,CrushSCI 收录了 CANCER BIOLOGY & THERAPY 的 11 篇完整审稿记录。最快一篇从收稿到录用用了 53 天(DNA polymerase theta (Polθ): a novel candidate for targeted cancer therapy,2026-05-18 收稿,2026-07-10 录用),最慢一篇用了 272 天;平均 116.2 天,中位数 99 天。

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。